BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Krupska I, Bruford EA, Chaqour B. Eyeing the Cyr61/CTGF/NOV (CCN) group of genes in development and diseases: highlights of their structural likenesses and functional dissimilarities. Hum Genomics 2015;9:24. [PMID: 26395334 DOI: 10.1186/s40246-015-0046-y] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
Number Citing Articles
1 Marinkovic M, Dai Q, Gonzalez AO, Tran ON, Block TJ, Harris SE, Salmon AB, Yeh CK, Dean DD, Chen XD. Matrix-bound Cyr61/CCN1 is Required to Retain the Properties of the Bone Marrow Mesenchymal Stem Cell Niche but is Depleted with Aging. Matrix Biol 2022:S0945-053X(22)00084-1. [PMID: 35752272 DOI: 10.1016/j.matbio.2022.06.004] [Reference Citation Analysis]
2 Al Haj Baddar N, Timoshevskaya N, Smith JJ, Guo H, Voss SR. Novel Expansion of Matrix Metalloproteases in the Laboratory Axolotl (Ambystoma mexicanum) and Other Salamander Species. Front Ecol Evol 2021;9:786263. [DOI: 10.3389/fevo.2021.786263] [Reference Citation Analysis]
3 Zaykov V, Chaqour B. The CCN2/CTGF interactome: an approach to understanding the versatility of CCN2/CTGF molecular activities. J Cell Commun Signal 2021. [PMID: 34613590 DOI: 10.1007/s12079-021-00650-2] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
4 Kong Y, Shao Y, Ren C, Yang G. Endometrial stem/progenitor cells and their roles in immunity, clinical application, and endometriosis. Stem Cell Res Ther 2021;12:474. [PMID: 34425902 DOI: 10.1186/s13287-021-02526-z] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
5 Silva ESD, Amaral C, Barreta M, Antoniazzi A, Andrade LG, Ferreira R, Mesquita F, Portela VM, Gonçalves PB. FGF18 modulates CTGF mRNA expression in cumulus-oocyte complexes and early bovine embryos: preliminary data. Zygote 2021;:1-5. [PMID: 34405788 DOI: 10.1017/S0967199421000599] [Reference Citation Analysis]
6 Peng L, Wei Y, Shao Y, Li Y, Liu N, Duan L. The Emerging Roles of CCN3 Protein in Immune-Related Diseases. Mediators Inflamm 2021;2021:5576059. [PMID: 34393649 DOI: 10.1155/2021/5576059] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Feng B, Xu G, Sun K, Duan K, Shi B, Zhang N. Association of serum Cyr61 levels with peripheral arterial disease in subjects with type 2 diabetes. Cardiovasc Diabetol 2020;19:194. [PMID: 33222686 DOI: 10.1186/s12933-020-01171-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Duan L, Schimmelmann M, Wu Y, Reisch B, Faas M, Kimmig R, Winterhager E, Köninger A, Gellhaus A. CCN3 Signaling Is Differently Regulated in Placental Diseases Preeclampsia and Abnormally Invasive Placenta. Front Endocrinol (Lausanne) 2020;11:597549. [PMID: 33304321 DOI: 10.3389/fendo.2020.597549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wong WY, Gilman K, Limesand KH. Yap activation in irradiated parotid salivary glands is regulated by ROCK activity. PLoS One 2020;15:e0232921. [PMID: 33151927 DOI: 10.1371/journal.pone.0232921] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Chen Z, Zhang N, Chu HY, Yu Y, Zhang ZK, Zhang G, Zhang BT. Connective Tissue Growth Factor: From Molecular Understandings to Drug Discovery. Front Cell Dev Biol 2020;8:593269. [PMID: 33195264 DOI: 10.3389/fcell.2020.593269] [Cited by in Crossref: 11] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
11 Ohkawara B, Kobayakawa A, Kanbara S, Hattori T, Kubota S, Ito M, Masuda A, Takigawa M, Lyons KM, Ishiguro N, Ohno K. CTGF/CCN2 facilitates LRP4-mediated formation of the embryonic neuromuscular junction. EMBO Rep 2020;21:e48462. [PMID: 32558157 DOI: 10.15252/embr.201948462] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
12 Moon S, Lee S, Caesar JA, Pruchenko S, Leask A, Knowles JA, Sinon J, Chaqour B. A CTGF-YAP Regulatory Pathway Is Essential for Angiogenesis and Barriergenesis in the Retina. iScience 2020;23:101184. [PMID: 32502964 DOI: 10.1016/j.isci.2020.101184] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
13 Chaqour B, Karrasch C. Eyeing the Extracellular Matrix in Vascular Development and Microvascular Diseases and Bridging the Divide between Vascular Mechanics and Function. Int J Mol Sci 2020;21:E3487. [PMID: 32429045 DOI: 10.3390/ijms21103487] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
14 Maiese K. Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways. Expert Rev Clin Pharmacol 2020;13:23-34. [PMID: 31794280 DOI: 10.1080/17512433.2020.1698288] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
15 Shea CA, Rolfe RA, McNeill H, Murphy P. Localization of YAP activity in developing skeletal rudiments is responsive to mechanical stimulation. Dev Dyn 2020;249:523-42. [PMID: 31747096 DOI: 10.1002/dvdy.137] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
16 Lee S, Ahad A, Luu M, Moon S, Caesar J, Cardoso WV, Grant MB, Chaqour B. CCN1-Yes-Associated Protein Feedback Loop Regulates Physiological and Pathological Angiogenesis. Mol Cell Biol 2019;39:e00107-19. [PMID: 31262999 DOI: 10.1128/MCB.00107-19] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
17 Park MH, Kim AK, Manandhar S, Oh SY, Jang GH, Kang L, Lee DW, Hyeon DY, Lee SH, Lee HE, Huh TL, Suh SH, Hwang D, Byun K, Park HC, Lee YM. CCN1 interlinks integrin and hippo pathway to autoregulate tip cell activity. Elife 2019;8:e46012. [PMID: 31429823 DOI: 10.7554/eLife.46012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
18 Chaqour B. Caught between a "Rho" and a hard place: are CCN1/CYR61 and CCN2/CTGF the arbiters of microvascular stiffness? J Cell Commun Signal 2020;14:21-9. [PMID: 31376071 DOI: 10.1007/s12079-019-00529-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
19 Quesnel K, Shi-Wen X, Hutchenreuther J, Xiao Y, Liu S, Peidl A, Naskar D, Siqueira WL, O'Gorman DB, Hinz B, Stratton RJ, Leask A. CCN1 expression by fibroblasts is required for bleomycin-induced skin fibrosis. Matrix Biol Plus 2019;3:100009. [PMID: 33543008 DOI: 10.1016/j.mbplus.2019.100009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
20 Li Z, Yan G, Diao Q, Yu F, Li X, Sheng X, Liu Y, Dai Y, Zhou H, Zhen X, Hu Y, Péault B, Ding L, Sun H, Li H. Transplantation of human endometrial perivascular cells with elevated CYR61 expression induces angiogenesis and promotes repair of a full-thickness uterine injury in rat. Stem Cell Res Ther 2019;10:179. [PMID: 31215503 DOI: 10.1186/s13287-019-1272-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
21 Tsou PS, Khanna D, Sawalha AH. Identification of Cysteine-Rich Angiogenic Inducer 61 as a Potential Antifibrotic and Proangiogenic Mediator in Scleroderma. Arthritis Rheumatol 2019;71:1350-9. [PMID: 30884213 DOI: 10.1002/art.40890] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
22 Fan Y, Yang X, Zhao J, Sun X, Xie W, Huang Y, Li G, Hao Y, Zhang Z. Cysteine-rich 61 (Cyr61): a biomarker reflecting disease activity in rheumatoid arthritis. Arthritis Res Ther 2019;21:123. [PMID: 31113467 DOI: 10.1186/s13075-019-1906-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
23 Su X, Wei Y, Cao J, Wu X, Mou D, Luo J, Li A, Zuo GW, Tang M. CCN3 and DLL1 co-regulate osteogenic differentiation of mouse embryonic fibroblasts in a Hey1-dependent manner. Cell Death Dis 2018;9:1188. [PMID: 30538222 DOI: 10.1038/s41419-018-1234-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
24 Chai KX, Chen YQ, Fan PL, Yang J, Yuan X. STROBE: The correlation of Cyr61, CTGF, and VEGF with polymyositis/dermatomyositis. Medicine (Baltimore) 2018;97:e11775. [PMID: 30142763 DOI: 10.1097/MD.0000000000011775] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
25 Nivison MP, Meier KE. The role of CCN4/WISP-1 in the cancerous phenotype. Cancer Manag Res 2018;10:2893-903. [PMID: 30214284 DOI: 10.2147/CMAR.S133915] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
26 Chaqour J, Lee S, Ravichandra A, Chaqour B. Abscisic acid - an anti-angiogenic phytohormone that modulates the phenotypical plasticity of endothelial cells and macrophages. J Cell Sci 2018;131:jcs210492. [PMID: 29361545 DOI: 10.1242/jcs.210492] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
27 Labrousse-arias D, Martínez-ruiz A, Calzada MJ. Hypoxia and Redox Signaling on Extracellular Matrix Remodeling: From Mechanisms to Pathological Implications. Antioxidants & Redox Signaling 2017;27:802-22. [DOI: 10.1089/ars.2017.7275] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
28 Lee S, Elaskandrany M, Lau LF, Lazzaro D, Grant MB, Chaqour B. Interplay between CCN1 and Wnt5a in endothelial cells and pericytes determines the angiogenic outcome in a model of ischemic retinopathy. Sci Rep 2017;7:1405. [PMID: 28469167 DOI: 10.1038/s41598-017-01585-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
29 Takayama I, Tanabe H, Nishiyama T, Ito H, Amizuka N, Li M, Katsube KI, Kii I, Kudo A. Periostin is required for matricellular localization of CCN3 in periodontal ligament of mice. J Cell Commun Signal 2017;11:5-13. [PMID: 28013443 DOI: 10.1007/s12079-016-0371-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
30 Yeger H, Perbal B. CCN family of proteins: critical modulators of the tumor cell microenvironment. J Cell Commun Signal. 2016;10:229-240. [PMID: 27517291 DOI: 10.1007/s12079-016-0346-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 5.2] [Reference Citation Analysis]
31 Butler GS, Connor AR, Sounni NE, Eckhard U, Morrison CJ, Noël A, Overall CM. Degradomic and yeast 2-hybrid inactive catalytic domain substrate trapping identifies new membrane-type 1 matrix metalloproteinase (MMP14) substrates: CCN3 (Nov) and CCN5 (WISP2). Matrix Biol 2017;59:23-38. [PMID: 27471094 DOI: 10.1016/j.matbio.2016.07.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
32 Klenotic PA, Zhang C, Lin Z. Emerging roles of CCN proteins in vascular development and pathology. J Cell Commun Signal 2016;10:251-7. [PMID: 27241177 DOI: 10.1007/s12079-016-0332-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
33 Maiese K. Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR. Neural Regen Res 2016;11:372-85. [PMID: 27127460 DOI: 10.4103/1673-5374.179032] [Cited by in Crossref: 24] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
34 Maiese K. Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders. Br J Clin Pharmacol 2016;82:1245-66. [PMID: 26469771 DOI: 10.1111/bcp.12804] [Cited by in Crossref: 82] [Cited by in F6Publishing: 103] [Article Influence: 11.7] [Reference Citation Analysis]